BRÈVE

sur Medacta Group SA (isin : CH0468525222)

Medacta Expands Hip Revision Platform in Europe

Medacta Group SA has announced enhancements to its Hip Revision Platform in Europe. The platform now includes a comprehensive femoral and acetabular portfolio, aiming to improve solutions for complex hip revision surgeries. Medacta emphasizes medical education programs led by Key Opinion Leaders to support surgeons in these procedures.

The M-Vizion Femoral Revision System is central to the femoral enhancements. It offers stability and versatility with options like a modular and monobloc version. For acetabular revisions, the Mpact System features advanced biomaterials for stability and bone integration, offering solutions for complex cases.

Medacta remains dedicated to hip revision research and personalized patient solutions. Their advanced technologies will be showcased at major European congresses, including those in Berlin, Rome, and Paris.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Medacta Group SA